​

Funding Round

Seed Round - OverT Bio

Seed Round - OverT Bio

Investment Firm

Overview

OverT Bio operates as a biotech company that provide cell therapy for cancers.

Announced Date

May 06, 2024

Funding Type

Seed

Highlights

Location

New York, New York, United States, North America

Social

Investor Lead

Wing Venture Capital

Wing Venture Capital

Wing Venture Capital is a early_stage_venture and initial_coin_offering and late_stage_venture and seed and venture firm.

Artis Ventures (AV)

Artis Ventures (AV)

Artis Ventures (AV) is a convertible_note and early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

8

Investor Name
Participant InvestorFusion Fund
Participant InvestorCancer Research Institute
Participant InvestorGaingels
Participant InvestorArtis Ventures (AV)
Participant InvestorWing Venture Capital

Round Details and Background

OverT Bio raised $16000000 on 2024-05-06 in Seed Round

OverT Bio operates as a biotech company that provide cell therapy for cancers.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 06, 2024
Seed Round - OverT Bio
9-16.0M

Recent Activity

There is no recent news or activity for this profile.